109677 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Polynucleotides for use in AAV production
#2RECOMBINANT AAV VECTORS FOR TREATING MUSCULAR DYSTROPHY
#3A CHIMERIC HELPER NUCLEIC ACID MOLECULE COMPRISING HELPER ELEMENTS FROM THREE DISTINCT HELPER VIRUSES
#4TUMOR-SELECTIVE E1A AND E1B MUTANTS
#5ADENOVIRUS-BASED NUCLEIC ACIDS AND METHODS THEREOF
#6RECOMBINANT CHIMERIC ADENOVIRAL VECTOR SUBSTITUTED BY KNOB GENE OF CHIMPANZEE ADENOVIRUS SEROTYPE 6, AND APPLICATION THEREOF
#7COMPOSITIONS AND METHODS FOR RECOMBINANT AAV PRODUCTION
#8COMPOSITIONS AND METHODS FOR RECOMBINANT AAV PRODUCTION
#9RECOMBINANT VIRUS-LIKE PARTICLE CAPSID VACCINES AGAINST ADENOVIRUSES AND COMPOSITIONS, METHODS, AND USE THEREOF
#10Novel chimpanzee adenovirus vector, construction method therefor, and application thereof
#11ADENOVIRAL HELPER PLASMID
#12ONCOLYTIC ADENOVIRUSES FOR TREATING CANCER
#13METHODS AND COMPOSITIONS FOR PROMOTING SURVIVAL & PROLIFERATION OF ENDOTHELIAL CELLS & STIMULATING ANGIOGENESIS
#14A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoter
#15ADENOVIRUS FOR ANTI-TUMOUR THERAPY
#16USE OF ONCOLYTIC ADENOVIRUS FOR THE TREATMENT OF PEDIATRIC BRAIN CANCER
#17Covalently-modified steroid acid-peptides having enhanced stability and/or biological activity
#18MODIFIED ADENOVIRUS
#19GENE THERAPY FOR RETINAL DISEASES
#20Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor
#21SYNTHETIC ADENOVIRUSES TARGETING BONE TISSUE AND USES THEREOF
#22Tumor-selective E1a and E1b mutants
#23METHODS AND COMPOSITIONS FOR PRODUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUSES
#24VIRAL BIOSENSORS
#25Engineered Polypeptides Derived From Variable Domain of Adenovirus Penton Base
#26DETARGETED ADENOVIRUS VARIANTS AND RELATED METHODS
#27ADENOVIRUS COMPRISING A MODIFIED ADENOVIRUS HEXON PROTEIN
#28ADENOVIRUS VECTORS AND USES THEREOF
#29VIRUSES WITH MODIFIED CAPSID PROTEINS
#30Chimeric protein and related genic transfer technology
#31ONCOLYTIC NON-HUMAN ADENOVIRUSES AND USES THEREOF
#32AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2 IN LIQUID FORM (VARIANTS)
#33ENGINEERED ENDOTHELIAL CELLS EXPRESSING AN ETS TRANSCRIPTION FACTOR
#34Adenoviral coat protein derived delivery vehicles
#35ONCOLYTIC ADENOVIRAL VECTOR EXPRESSING PEPTIDYLARGININE DEIMINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE
#36Desmoglein 2 (DSG2) binding proteins and uses therefor
#37CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS
#38ADENOSOMES
#39MODULATION OF ANTIGEN IMMUNOGENICITY BY DELETING EPITOPES RECOGNIZED BY NKT CELLS
#40Multimerizing Polypeptides Derived From Jelly Roll Fold Domain of Adenovirus Penton Base
#41RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS
#42ADENOVECTORS FOR DELIVERY OF THERAPEUTIC GENETIC MATERIAL INTO T CELLS
#43Blood-brain barrier comprising engineered endothelial cells
#44MODIFIED SEROTYPE 28 ADENOVIRAL VECTORS
#45CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS
#46Simian adenovirus vectors comprising the ChAd-157 fiber protein
#47Adenovirus and uses thereof
#48Tumor-selective E1A and E1B mutants
#49Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis
#50Targeted delivery system
#51Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
#52Recombinant adenoviruses and stem cells comprising same
#53Simian (gorilla) adenovirus or adenoviral vectors and methods of use
#54ONCOLYTIC ADENOVIRUS COMPOSITIONS WITH ENHANCED REPLICATION PROPERTIES
#55Adenovirus vectors and uses thereof
#56CONJUGATABLE DESMOGLEIN 2 (DSG2) BINDING PROTEINS AND USES THEREFOR
#57Adenoviral coat protein derived delivery vehicles
#58Adenovirus and uses thereof
#59Eukaryotic cell line
#60Desmoglein 2 (DSG2) binding proteins and uses therefor
#61Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#62Life-cycle-defective adenovirus helper viruses, their production and use for producing rAAV
#63Hexon protein hypervariable region gene sequence of adenovirus and its application
#64Adenovirus comprising an albumin-binding moiety
#65Adenovirus polynucleotides and polypeptides
#66Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof
#67Use of adenovirus and nucleic acids coding therefor
#68Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter
#69NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS WITH ENHANCED HUMAN SKELETAL MUSCLE TROPISM
#70Detargeted adenovirus variants and related methods
#71Oncolytic adenoviruses for treating cancer
#72Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#73SYNTHETIC ADENOVIRUSES TARGETING BONE TISSUE AND USES THEREOF
#74Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#75Adenovectors for delivery of therapeutic genetic material into T cells
#76Tumor-selective E1a and E1b mutants
#77PRODUCTION OF VIRAL VECTORS
#78Hexon protein hypervariable region gene sequence of adenovirus and its application
#79Desmoglein 2 (DSG2) binding proteins and uses therefor
#80Simian (gorilla) adenovirus or adenoviral vectors and methods of use
#81Use of adenovirus and nucleic acids coding therefor
#82Oncolytic adenoviruses with increased proportion of the 156R splicing isoform of the E1B protein
#83Isolating traffic-enhancing mutants of drug delivery protein
#84Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis
#85Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration
#86Engineered endothelial cells expressing an ETS transcription factor
#87Adenovirus polynucleotides and polypeptides
#88Anti-tumor medicament based on adenovirus
#89Oncolytic adenoviruses with mutations in immunodominant adenovirus epitopes and their use in cancer treatment
#90Immunization of avians by administration of non-replicating vectored vaccines
#91Modified serotype 28 adenoviral vectors
#92Detargeted adenovirus variants and related methods
#93Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#94RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS
#95Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof
#96Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#97Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells
#98Use of adenovirus and nucleic acids coding therefor
#99Multitargeting onocolytic adenovirus, methods of use, and methods of making
#100MODIFICATION OF RECOMBINANT ADENOVIRUS WITH IMMUNOGENIC PLASMODIUM CIRCUMSPOROZOITE PROTEIN EPITOPES
#101Use of BMP4 for thymic regeneration
#102Desmoglein 2 (DSG2) binding proteins and uses therefor
#103Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#104Production of viral vectors
#105ONCOLYTIC TUMOR VIRUSES AND METHODS OF USE
#106Recombinant AAV vectors useful for reducing immunity against transgene products
#107Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
#108Targeted adenoviruses and methods of making, isolating, and using
#109Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
#110Adenovirus comprising an albumin-binding moiety
#111ADENOVIRAL TARGETING, COMPOSITIONS AND METHODS THEREFOR
#112Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#113Adenovirus isolated from titi monkeys
#114Desmoglein 2 (DSG2) binding proteins and uses therefor
#115Puma protein expression vector and use thereof in gene therapy
#116Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#117MODIFIED ADENOVIRUS HEXON PROTEIN AND USES THEREOF
#118Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof
#119Vault complexes
#120Vectors and methods for genetic immunization
#121Vectors and methods for genetic immunization
#122Methods of propagating monkey adenoviral vectors
#123Oncolytic adenoviruses with increased proportion of the 156R splicing isoform of the E1B protein
#124Oncolytic adenovirus armed with therapeutic genes
#125Isolating traffic-enhancing mutants of drug delivery protein
#126Elimination of immune responses to viral vectors
#127Modified serotype 28 adenoviral vectors
#128Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#129Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
#130Simian adenovirus 41 and uses thereof
#131Enhanced glycemic control using Ad36E4orf1 and AKT1 inhibitor
#132Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection
#133Enhancement of protein production yield mediated by a fast shuttling CDC42 GTPase
#134Simian (gorilla) adenovirus or adenoviral vectors and methods of use
#135Adenoviral vector-based respiratory syncytial virus (RSV) vaccine
#136Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#137Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#138Production of viral vectors
#139Simian subfamily E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 and uses thereof
#140Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
#141Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#142Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis
#143Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof
#144Immunization of avians by administration of non-replicating vectored vaccines
#145Vault complexes for facilitating biomolecule delivery
#146Adenoviral vector-based dengue fever vaccine
#147Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof
#148Compositions and methods for retargeting virus constructs
#149Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof
#150Hexon Tat-PTD modified adenovirus and uses thereof
#151Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells
#152Anti-cancer adenoviruses
#153Adenovirus vaccine vectors
#154HEXON ISOLATED FROM SIMIAN ADENOVIRUS SEROTYPE 19, HYPERVARIABLE REGION THEREOF AND CHIMERIC ADENOVIRUS USING THE SAME
#155Adenovirus isolated from Titi Monkeys
#156Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#157IMMORTALIZED AVIAN CELL LINES FOR VIRUS PRODUCTION
#158Methods of propagating monkey adenoviral vectors
#159Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
#160Simian adenovirus 41 and uses thereof
#161Productivity augmenting protein factor, novel cell lines and uses thereof
#162Oncolytic adenoviruses for treating cancer
#163Adenovirus dodecahedron particles for delivery of pharmaceutical agents
#164Simian Adenovirus Vectors and Methods of Use
#165Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#166NON-AD5 ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
#167Adenoviral VA1 Pol III expression system for RNAi expression
#168METHODS AND REAGENTS FOR EFFICIENT AND TARGETED GENE TRANSFER TO MONOCYTES AND MACROPHAGES
#169Adenovirus 36 E4 ORF 1 Gene and Protein and Their Uses
#170Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
#171Recombinant adenovirus vector having a reduced side effect
#172Targeted delivery system
#173Tumor selective E1a and E1b mutants
#174Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
#175Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
#176Vault complexes for facilitating biomolecule delivery
#177Adipogenic Adenoviruses As A Biomarker For Disease
#178ADENOVIRUS PARTICLES HAVING A CHIMERIC ADENOVIRUS SPIKE PROTEIN, USE THEREOF AND METHODS FOR PRODUCING SUCH PARTICLES
#179Subunits of the adenovirus fiber protein and uses thereof as vaccines
#180Elimination of immune responses to viral vectors
#181Modulation of Adenoviral Tropism
#182VACCINES FOR PREVENTION AND TREATMENT OF ADDICTION
#183Capsid-Incorporated Antigen for Novel Adenovirus Vaccine
#184Adenoviruses Mutated In The VA Genes For Cancer Treatment
#185Production of viral vectors
#186Use of adenovirus and nucleic acids coding therefor
#187Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof
#188Packaging cells for recombinant adenovirus
#189Vectors and method for genetic immunization
#190NUCLEIC ACID SEQUENCES FOR THE AMPLIFICATION AND DETECTION OF RESPIRATORY VIRUSES
#191Simian subfamily C adenoviruses SAdV-40, -31, and -34 and uses thereof
#192Compositions and methods for modulating the activity of complement regulatory proteins on target cells
#193Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof
#194Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38
#195Eukaryotic layered vector initiation systems
#196Adenovirus with mutations in the endoplasmic reticulum retention domain of the E3-19K protein and their use in cancer treatment
#197Oncolytic Adenoviruses and Uses Thereof
#198Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof
#199METHOD FOR THE PRODUCTION AND PURIFICATION OF RETROVIRAL VECTORS
#200Replication-competent anti-cancer vectors
#201Serotype of adenovirus and uses thereof
#202PORCINE ADENOVIRUS E1 AND E4 REGIONS
#203Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
#204CD 40 Binding Molecules and CTL Pepetides for Treating Tumors
#205Adenovirus 36 E4 orf 1 gene and protein and their uses
#206Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
#207ADENOVIRUS STATUS AS A PREDICTOR OF BODY COMPOSITION CHANGE, DISEASE STATUS, AND TREATMENT OUTCOMES
#208Simian adenovirus vectors and methods of use
#209Viral core protein-cationic lipid-nucleic acid-delivery complexes
#210ADENOVIRUSES MUTATED IN THE VA GENES FOR CANCER TREATMENT
#211Oncolytic adenovirus armed with therapeutic genes
#212Recombinant protein production in a human cell
#213NON-VIRAL GENE DELIVERY COMPLEX
#214Adenoviral vector-based malaria vaccines
#215CYTOTOXIC T-CELL EPITOPE PEPTIDE AND USE THEREOF
#216NOVEL RECOMBINANT ADENOVIRUS VECTOR HAVING A REDUCED SIDE EFFECT
#217Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
#218Adipogenic adenoviruses as a biomarker for disease
#219Adipogenic adenoviruses as a biomarker for disease
#220Modified Adenovirus Hexon Protein and Uses Thereof
#221Compositions and methods for generating and screening adenoviral libraries
#222Optical Disc Apparatus
#223Helper virus-free AAV production
#224Recombinant protein production in a human cell
#225Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations
#226Immortalized avian cell lines for virus production
#227Method for rapid screening of bacterial transformants and novel simian adenovirus proteins
#228Means and methods for regulating gene expression
#229Adenoviral vectors and uses thereof
#230Substances for preventing and treating autoimmune diseases
#231SUBSTANCES FOR PREVENTING AND TREATING AUTOIMMUNE DISEASES
#232Serotype of adenovirus and uses thereof
#233Packaging systems for human recombinant adenovirus to be used in gene therapy
#234Means and methods for regulating gene expression
#235Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
#236Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#237Identification of self and non-self antigens implicated in autoimmune disease
#238Adenoviruses mutated in the VA genes for cancer treatment
#239Methods and means for producing proteins with predetermined post-translational modifications
#240ADENOVIRUS FIBER SHAFT COMPOSITION AND METHODS OF USE
#241Methods of producing erythropoietin isoforms comprising Lewis-X structures and high sialic acid content and compositions of the same
#242Methods and compositions to induce antitumor response
#243Over-expression of enzymes involved in post-translational protein modifications in human cells
#244Polyvalent Viral Vectors and a System for Production Thereof
#245Adipogenic adenoviruses as a biomarker for disease
#246Immunization of avians by administration of non-replicating vectored vaccines
#247Method for the production and purification of adenoviral vectors
#248Methods to culture circovirus
#249Methods and means for producing proteins with predetermined post-translational modifications
#250Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
#251Adenovirus status as a predictor of body composition change, disease status, and treatment outcomes
#252Recombinant protein production in a human cell
#253Subunits of the adenovirus fiber protein and uses thereof as vaccines
#254Serotype of adenovirus and uses thereof
#255Method of preparing a proliferation-regulated recombinant adenoviral vector efficiently and kit for preparing the same
#256Polynucleotides for use in recombinant adeno-associated virus virion production
#257Production of pseudotyped recombinant AAV virions
#258Modified fiber proteins for efficient receptor binding
#259Capsid-modified adenovirus vectors and methods of using the same
#260Recombinant modified adenovirus fiber protein
#261Cell lines for production of replication-defective adenovirus
#262Packaging systems for human recombinant adenovirus to be used in gene therapy
#263Use of adenoviruses mutated in the VA genes for cancer treatment
#264Modified adenoviral fiber with ablated to cellular receptors
#265Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
#266Viral agents
#267Packaging cells for recombinant adenovirus
#268Enhancement of adenoviral oncolytic activity by modification of the E1A gene product
#269Oncolytic adenovirus armed with therapeutic genes
#270Method of using adenoviral vectors with increased persistence in vivo
#271Recombinant expression of factor VIII in human cells
#272Novel use of adenoviruses and nucleic acids coding therefor
#273Adenovirus vectors for immunotherapy
#274Fiber-modified adenoviral vectors for enhanced transduction of tumor cells
#275Adenoviruses, nucleic acids coding therefor, and use thereof
#276Helper virus-free AAV production
#277Replication-competent anti-cancer vectors
#278Minimal lentiviral vector system
#279Chimeric adenoviruses
#280Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
#281Targeted adenovirus vectors for delivery of heterologous genes
#282Vectors and methods for gene transfer
#283Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
#284Packaging systems for human recombinant adenovirus to be used in gene therapy
#285Conditionally replicative adenovirus to target the Rb and Rb-related pathways
#286Substances for preventing and treating autoimmune diseases
#287Methods to culture circovirus
#288Serotype of adenovirus and uses thereof
#289Recombinant virus production for the manufacturing of vaccines
#290Means and methods for regulating gene expression
#291Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
#292Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins
#293Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
#294Methods and means for producing proteins with predetermined post-translational modifications
#295Accessory functions for use in recombinant AAV virion production
#296Overexpression of enzymes involved in post-translational protein modifications in human cells
#297BAV packaging regions and E1 transcriptional control regions
#298Efficient production of IgA in recombinant mammalian cells
#299Method for the production and purification of adenoviral vectors
#300Serotype of adenovirus and uses thereof